Further experiments determining the role of Rac and Rho in RasGRP3-induced cell migration, as well as analysis of other downstream effectors such as Erk1/2 are needed to further define the mechanisms of RasGRP3-induced glioma cell migration via Ras activation. This evidence concerns the gene AKT1 and central nervous system cancer.